Thermo Scientific AcroMetrix Coronavirus 2019 (COVID-19) RNA Control

Monday, 06 April, 2020 | Supplied by: Thermo Fisher Scientific

In an effort to combat the recent coronavirus outbreak, Thermo Fisher Scientific has designed and developed the Thermo Scientific AcroMetrix Coronavirus 2019 (COVID-19) RNA Control as a synthetic RNA, non-infectious control to help labs validate and monitor COVID-19 molecular diagnostic tests. Taking FDA guidelines into account, the controls were carefully designed at two different concentrations: a low positive control and an ultralow positive control.

The control is prepared by formulating synthetic RNA transcripts that contain N, S, E and Orf1ab regions of SARS-CoV-2 (COVID-19) genome into a proprietary buffer. The RNA is ready for reverse transcription, PCR amplification and detection, as appropriate to the test. The kit contains two vials of SARS-CoV-2 specific RNA at the concentration that will result low positive and ultralow positive in most commonly used PCR-based COVID-19 nucleic acid testing methods.

The control is available globally as a Research Use Only (RUO) product and is not intended for clinical use.

Phone: 1300 735 292
Related Products

Merck ColorWheel flow cytometry antibodies and dyes

The portfolio allows users to independently select antibodies and dyes for assembly in any...

Matreya antibodies directed against ganglioside and globoside glycolipids

Matreya has a range of monoclonal and polyclonal antibodies directed against the carbohydrate...

Affinity Biosciences phospho-specific antibodies

Affinity Biosciences is an original manufacturer of phospho-specific antibodies, offering over...

  • All content Copyright © 2021 Westwick-Farrow Pty Ltd